|
peroxiredoxin 6005, Drosophila
|
C560266 |
|
|
cytokine-induced apoptosis inhibitor 1, rat
|
C560267 |
|
|
diphenylmethyltin chloride
|
C560268 |
|
|
1,4-bis(diphenylchlorostannyl)-p-xylene
|
C560269 |
|
|
Cell- and Tissue-Based Therapy
|
D064987 |
[Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.
] |
|
Streptogramin B
|
D025381 |
[A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria.
] |
|
Streptogramin Group B
|
D025382 |
[A structural subclass of streptogramins. They are cyclic hexadepsipeptides with approximate molecular weight of 800 that contain a characteristic 3-hydroxy picolinoyl exocyclic component.
] |
|
Lipid Metabolism
|
D050356 |
[Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS.
] |
|
XZH-5 compound
|
C560270 |
|
|
3-(3-chlorophenoxymethyl)-1-(tetrahydropyran-4-yl)-1H-pyrazolo(3,4-d)pyrimidin-4-ylamine
|
C560271 |
|
|
cyclohexanecarboxylic acid (3-(2,5-dimethylbenzyloxy)-4-(methanesulfonylmethylamino)phenyl)amide
|
C560272 |
|
|
Premature ovarian failure, familial
|
C535272 |
|
|
2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-(2'',6''-di-O-(3'''-(4-fluorophenylpropanoyl)))galactosyl-4H-chromen-4-one
|
C560273 |
|
|
Presenile dementia, Kraepelin type
|
C535273 |
|
|
ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate
|
C560274 |
|
|
Prieto X-linked mental retardation syndrome
|
C535274 |
|
|
GSK 163929
|
C560275 |
|
|
Primary angiitis of the central nervous system
|
C535276 |
|
|
Primary ciliary dyskinesia, 2
|
C535277 |
|
|
perchlorotriphenylmethyl triethylester radical
|
C560278 |
|
